DrugPatentWatch - Biopharmaceutical Business Intelligence
Profile for Concert Pharmaceuticals, Inc. (CNCE)
« Back to company indexCNCE Chatter Timeline
Stock Ticker for CNCE
Most Active Tweeters for CNCE
| User | Tweets |
|---|---|
| @reurope_stock | 12 |
| @whatsonthorold2 | 12 |
| @bibeypost_stock | 11 |
| @mmahotstuff1 | 10 |
| @thefinreviewer | 7 |
Recent Tweets for CNCE
 |
@thefinreviewer Comparing of Infinity Pharmaceuticals Inc. $CNCE https://t.co/nJDJJlW44d February 21st 2019, 10:02pm |
 |
@whatsonthorold2 Analysts See $-0.74 EPS for Concert Pharmaceuticals, Inc. $CNCE https://t.co/kqQ8nBWd2s February 21st 2019, 6:02pm |
 |
@bibeypost_stock Concert Pharmaceuticals, Inc. $CNCE Analysts See $-0.74 EPS https://t.co/dax2LouI9D February 21st 2019, 6:02pm |
|
@thefinreviewer Reviewing CytRx Corporation $CNCE's results https://t.co/W0cmIq9cg6 February 21st 2019, 5:02pm |
 |
@bulletin_en EPS for Concert Pharmaceuticals, Inc. $CNCE Expected At $-0.74 on March, 7 https://t.co/dKsjWDaXja February 21st 2019, 4:02pm |
 |
@BioAnalysisCent $CNCE Biotech Analysis Central "Concert Pharmaceuticals Could Have First Oral Drug For Patients With Sudden Hair Lo… https://t.co/0wAFUo6Zfg February 21st 2019, 11:02am |
 |
@NewsToDesk $CNCE: Concert Pharmaceuticals to Report Full Year 2018 Results on …: https://t.co/E63vcbymOF February 21st 2019, 7:02am |
|
@whatsonthorold2 After Forming Bearish Double Bottom Chart Pattern, Is Concert Pharmaceuticals, Inc. $CNCE's Near-Term Analysis Nega… https://t.co/d5p6sOMdNp February 21st 2019, 6:02am |
 |
@reurope_stock Could Concert Pharmaceuticals, Inc. $CNCE See a Reversal After Having Formed Several Months Double Bottom https://t.co/dRgAoepHNC February 21st 2019, 6:02am |
 |
@TickerReport Concert Pharmaceuticals Inc $CNCE Receives Average Rating of “Buy” from Analysts https://t.co/XwXYkMXnxF February 20th 2019, 9:02pm |
 |
@WatchlistN Concert Pharmaceuticals Inc $CNCE Given Consensus Rating of “Buy” by Brokerages https://t.co/HriCqVJhgD February 20th 2019, 8:02pm |
 |
@mmahotstuff1 $-0.74 EPS Expected for Concert Pharmaceuticals, Inc. $CNCE https://t.co/TX0iCwF5IK February 20th 2019, 7:02pm |
|
@whatsonthorold2 Analysts See $-0.74 EPS for Concert Pharmaceuticals, Inc. $CNCE https://t.co/D7NwHbi9HK February 20th 2019, 7:02pm |
|
@reurope_stock Analysts See $-0.74 EPS for Concert Pharmaceuticals, Inc. $CNCE https://t.co/N0iw9bzk4y February 20th 2019, 7:02pm |
|
@mmahotstuff1 Could Concert Pharmaceuticals Inc $CNCE Go Up After Its Newest Short Interest Report? https://t.co/MWKjQrKGP5 February 20th 2019, 12:02pm |
|
@whatsonthorold2 Is Concert Pharmaceuticals Inc $CNCE a Buy? The Stock Reported more Sellers https://t.co/xMCA4Ui7x5 February 20th 2019, 12:02pm |
|
@reurope_stock Could Concert Pharmaceuticals Inc $CNCE Change Direction After More Shorts? https://t.co/9X2O6j7A09 February 20th 2019, 11:02am |
|
@mmahotstuff1 EPS for Concert Pharmaceuticals, Inc. $CNCE Expected At $-0.74 https://t.co/z1LG9XDHJp February 19th 2019, 9:02pm |
|
@whatsonthorold2 $-0.74 EPS Expected for Concert Pharmaceuticals, Inc. $CNCE https://t.co/lIYQzZhpY3 February 19th 2019, 9:02pm |
|
@reurope_stock Concert Pharmaceuticals, Inc. $CNCE EPS Estimated At $-0.74 https://t.co/FR36lkKY5o February 19th 2019, 9:02pm |
|
@thefinreviewer Contrasting of Insmed Incorporated $CNCE https://t.co/jkN9lgooJZ February 19th 2019, 4:02pm |
 |
@vernermark RT @SeekingAlpha: $CNCE - Concert Pharmaceuticals Could Have First Oral Drug For Patients With Sudden Hair Loss https://t.co/wtFSPHcycV February 18th 2019, 8:02pm |
 |
@SeekingAlpha $CNCE - Concert Pharmaceuticals Could Have First Oral Drug For Patients With Sudden Hair Loss https://t.co/wtFSPHcycV February 18th 2019, 8:02pm |
|
@mmahotstuff1 EPS for Concert Pharmaceuticals, Inc. $CNCE Expected At $-0.74 https://t.co/9ePfU4mwot February 18th 2019, 7:02pm |
|
@whatsonthorold2 $-0.74 EPS Expected for Concert Pharmaceuticals, Inc. $CNCE https://t.co/tKBELUXdR4 February 18th 2019, 7:02pm |
|
@bibeypost_stock Concert Pharmaceuticals, Inc. $CNCE Analysts See $-0.74 EPS https://t.co/bySCxOEPH3 February 18th 2019, 7:02pm |
|
@reurope_stock $-0.74 EPS Expected for Concert Pharmaceuticals, Inc. $CNCE https://t.co/DpuIcD6hPx February 18th 2019, 7:02pm |
|
@bulletin_en Contrasting of G1 Therapeutics Inc. $CNCE https://t.co/WtovnxeSuK February 18th 2019, 2:02pm |
 |
@mhrob RT @Jdalexander64: @jesse_brodkin It’s less clear if $CNCE IP Holds up for CTP-543, although still has NCE 5-yr protection + other IP. We’l… February 18th 2019, 1:02pm |
|
@whatsonthorold2 Institutional Investors Sentiment Indicator of CONCERT PHARMACEUTICALS $CNCE Crashes in Q3 2018 https://t.co/2Sn0MrvyaH February 18th 2019, 8:02am |
|
@mmahotstuff1 $-0.74 EPS Expected for Concert Pharmaceuticals, Inc. $CNCE https://t.co/pasRNDOSWl February 17th 2019, 8:02pm |
|
@whatsonthorold2 Analysts See $-0.74 EPS for Concert Pharmaceuticals, Inc. $CNCE https://t.co/f32iVMMBKV February 17th 2019, 8:02pm |
|
@bibeypost_stock $-0.74 EPS Expected for Concert Pharmaceuticals, Inc. $CNCE https://t.co/8c8hMoJ37k February 17th 2019, 8:02pm |
|
@reurope_stock Concert Pharmaceuticals, Inc. $CNCE Analysts See $-0.74 EPS https://t.co/sOrG6H2Mkp February 17th 2019, 8:02pm |
|
@bulletin_en On March, 7 Analysts See $-0.74 EPS for Concert Pharmaceuticals, Inc. $CNCE https://t.co/ayl3w97Mri February 17th 2019, 6:02pm |
 |
@Jdalexander64 @jesse_brodkin It’s less clear if $CNCE IP Holds up for CTP-543, although still has NCE 5-yr protection + other IP.… https://t.co/1kozrWweyY February 17th 2019, 8:02am |
|
@mmahotstuff1 Is Concert Pharmaceuticals, Inc. $CNCE a Sell? The Stock Formed Bearish Double Bottom Pattern https://t.co/SDVLKacUf5 February 16th 2019, 6:02am |
|
@bibeypost_stock Is Selling Stock Like Concert Pharmaceuticals, Inc. $CNCE After This Double Bottom Winning Strategy? https://t.co/Vp0Q9hySka February 16th 2019, 6:02am |
|
@reurope_stock Concert Pharmaceuticals, Inc. $CNCE's Stock Formed A Several Months Bearish Double Bottom Chart Pattern https://t.co/2I7DFqVgTu February 16th 2019, 6:02am |
|
@bibeypost_stock Concert Pharmaceuticals, Inc. $CNCE Analysts See $-0.74 EPS https://t.co/7HUPqrkZzr February 15th 2019, 8:02pm |
|
@reurope_stock Concert Pharmaceuticals, Inc. $CNCE EPS Estimated At $-0.74 https://t.co/GAa1unYOel February 15th 2019, 8:02pm |
|
@whatsonthorold2 Analysts See $-0.74 EPS for Concert Pharmaceuticals, Inc. $CNCE https://t.co/6jY44De3m2 February 14th 2019, 11:02pm |
|
@bibeypost_stock $-0.74 EPS Expected for Concert Pharmaceuticals, Inc. $CNCE https://t.co/cRjOTpwkTO February 14th 2019, 11:02pm |
|
@thefinreviewer Amarin Corporation plc $CNCE Contrasting side by side https://t.co/YhqXyHrYXy February 14th 2019, 8:02pm |
|
@Jdalexander64 RT @odibro: $CNCE Selected for Late-Breaking Presentation of CTP-543 Phase 2 Data in Alopecia Areata at 2019 AAD Annual Meeting, March 2 h… February 14th 2019, 1:02pm |
|
@Jdalexander64 RT @mhrob: $CNCE Late-breaking Oral Presentation of CTP-543 P2 #AlopeciaAreata #AAD2019 https://t.co/QwG2OmarXk February 14th 2019, 1:02pm |
|
@mhrob RT @Jdalexander64: Otsuka's AVP-786 (w/ $CNCE) phase 2 trial for negative symptoms of schizophrenia is scheduled to shift to P3, joining le… February 14th 2019, 1:02pm |
 |
@SwingTradeBot 20 DMA Support today: $CNCE $NS ... https://t.co/deOpbNqdR6 February 14th 2019, 11:02am |
 |
@kag475 RT @ConcertPharma: The Concert $CNCE team rings the @Nasdaq closing bell with National Alopecia Areata Foundation and Bald Girls Do Lunch t… February 13th 2019, 6:02pm |
|
@thefinreviewer Contrasting of Alder Biopharmaceuticals Inc. $CNCE https://t.co/wYcUEsXUgo February 13th 2019, 6:02pm |
DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC
2004 - 2019. All rights reserved.